Bain Capital Life Sciences Investors, LLC

Q3 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    21

  • Value ($000)

    $1,506,676

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

HEARTFLOW INC

COM
$419.00 M
28 %

12,448,158

---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
$304.85 M
20 %

10,719,110

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
$289.29 M
19 %

3,020,990

---

PHARVARIS N V

COM
$79.37 M
5 %

3,181,275

OLMA
OLMA

OLEMA PHARMACEUTICALS INC

COM
$67.00 M
4 %

6,843,954

YB4P
YB4P

SAVARA INC

COM
$62.83 M
4 %

17,600,621

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
$51.78 M
3 %

1,315,892

---

SOLID BIOSCIENCES INC

COM NEW
$48.81 M
3 %

7,911,669

---

UPSTREAM BIO INC

COM
$45.89 M
3 %

2,439,538

RPID
RPID

RAPID MICRO BIOSYSTEMS INC

CLASS A COM
$28.17 M
2 %

8,434,560

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21